RECORDATI |
Market Closed -
Other stock markets
|
After market 03:14:00 pm | |||
| 49.26 EUR | +1.73% |
|
49.29 | +0.06% |
| 10:02am | Stock markets in the green; BPER Bank leads the rises | AN |
| May. 21 | Global markets live: Microsoft, Roche, BMW, Nintendo, Nordson... |  |
Business Summary
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Number of employees: 4,455
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Specialty & Primary Care
65.7
%
| 1,258 | 67.9 % | 1,368 | 65.7 % | +8.75% |
Rare Diseases
34.3
%
| 596 | 32.1 % | 715 | 34.3 % | +19.96% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Europe
56.4
%
| 1,084 | 58.5 % | 1,175 | 56.4 % | +8.37% |
America
19.0
%
| 324 | 17.5 % | 395 | 19.0 % | +22.06% |
Italy
15.2
%
| 277 | 15.0 % | 317 | 15.2 % | +14.36% |
Australasia
6.7
%
| 115 | 6.2 % | 140 | 6.7 % | +21.69% |
Africa
2.7
%
| 53 | 2.9 % | 56 | 2.7 % | +3.96% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Robert Koremans
CEO | Chief Executive Officer | 61 | 21-11-30 |
Luigi la Corte
DFI | Director of Finance/CFO | 54 | 19-10-31 |
Andrea Recordati
CHM | Chairman | 52 | 98-04-28 |
Raffaele Sabia
CTO | Chief Tech/Sci/R&D Officer | - | 17-06-30 |
Guido Guidi
BRD | Director/Board Member | 71 | 20-04-28 |
| Investor Relations Contact | 51 | 20-09-30 | |
| General Counsel | - | 23-03-31 | |
Bibianne Bon
LAW | General Counsel | - | 23-03-31 |
| Human Resources Officer | - | 22-12-31 | |
Gabriele Finzi
PRN | Corporate Officer/Principal | - | 07-12-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Cathrin Petty
BRD | Director/Board Member | 51 | 18-06-11 |
Robert Koremans
CEO | Chief Executive Officer | 61 | 21-11-30 |
Andrea Recordati
CHM | Chairman | 52 | 98-04-28 |
Giorgio de Palma
BRD | Director/Board Member | 49 | 20-04-28 |
Elisa Corghi
BRD | Director/Board Member | 51 | 22-04-28 |
| Director/Board Member | 56 | 20-04-28 | |
Luigi la Corte
DFI | Director of Finance/CFO | 54 | 19-10-31 |
| Director/Board Member | 53 | 14-04-16 | |
Guido Guidi
BRD | Director/Board Member | 71 | 20-04-28 |
| Director/Board Member | 60 | 19-02-04 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 209,125,156 | 97,587,009 ( 46.66 %) | 2,763,813 ( 1.322 %) | 46.66 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
RECORDATI 1.80% | 3,765,552 | 1.80% | 197,853,549 $ |
PURETECH HEALTH PLC 3.53% | 9,554,140 | 3.53% | 28,464,554 $ |
| 43,103 | 0.71% | 140,144 $ |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Herbacos Recordati sro
 Herbacos Recordati sro Household/Personal CareConsumer Non-Durables Part of CVC Advisers Ltd., Herbacos Recordati sro is a Czech company that manufactures and distributes cosmetic products. The company is located in Czechia. |
Household/Personal Care
|
Recordati AG
 Recordati AG Drugstore ChainsRetail Trade Recordati AG engages in the trading in as well as importation and exportation of pharmaceutical, biological, chemical, laboratory, and diagnostic products. It also provides consulting services in the areas of marketing and management, with focus on the pharmaceutical industry. The company was founded on June 8, 2011 and is headquartered in Baar, Switzerland. |
Drugstore Chains
|
Recordati Ilac San ve Tic AS
| |
Recordati BVBA
 Recordati BVBA Medical DistributorsDistribution Services Part of CVC Advisers Ltd., Recordati BV is a trading brokerage in pharmaceutical products and orthopedic articles. The company is located in Belgium. |
Medical Distributors
|
Recordati Ireland Ltd.
 Recordati Ireland Ltd. Pharmaceuticals: MajorHealth Technology Recordati Ireland Ltd. manufactures pharmaceutical products. It offers pharmaceuticals in the therapeutic areas of cardiovascular, antibiotics and antivirals, central nervous system, gastroenterology, dermatological, muscolo-skeletal disorders, genito-urinary system and pain therapy, obstetics and gynaecology and OTC (non-prescription pharmaceuticals). The company was founded in 2002 and is headquartered in Cork, Ireland. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.80% | 10.68B | |
| +48.53% | 780B | |
| +41.21% | 627B | |
| -6.37% | 353B | |
| +20.93% | 334B | |
| +8.21% | 296B | |
| +17.47% | 244B | |
| -0.86% | 217B | |
| +11.05% | 214B | |
| +4.40% | 161B |
- Stock Market
- Equities
- REC Stock
- Company Recordati
